SCHEMBL19806037

SCHEMBL19806037

Cc1ccc(O)c(NC(=O)CCCS(=O)(=O)c2nc(-c3cccs3)cc(C(F)(F)F)n2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SDHB P21912 3/20 1.00
▸ TP53 P04637 15/20 0.91
▸ MAPT P10636 7/20 0.91
▸ GAA P10253 4/20 0.91
▸ SMN1; SMN2 Q16637 5/20 0.74
▸ KDM4E B2RXH2 3/20 0.70
▸ ALDH1A1 P00352 3/20 0.70
▸ HPGD P15428 3/20 0.70
▸ HTT P42858 3/20 0.70
▸ NPSR1 Q6W5P4 2/20 0.70
▸ STAT1 P42224 1/20 0.70
▸ RAB9A P51151 1/20 0.70
▸ KMT2A Q03164 1/20 0.70
▸ PAX8 Q06710 1/20 0.70
▸ HSD17B10 Q99714 1/20 0.70
▸ S1PR4 O95977 1/20 0.59
▸ LMNA P02545 1/20 0.59
▸ S1PR1 P21453 1/20 0.59
▸ TDP1 Q9NUW8 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19806036 0.83 SDHB (0.71) SDHBTP53MAPTGAASMN1; SMN2
SCHEMBL19805767 0.81 SDHB (0.74) SDHBTP53MAPTGAASMN1; SMN2
SCHEMBL1199975 0.78 KDM4E (1.00) SDHBTP53MAPTGAASMN1; SMN2
SCHEMBL19806030 0.76 SDHB (0.86) SDHBTP53MAPTGAASMN1; SMN2
SCHEMBL29976120 0.75 SDHB (1.00) SDHBTP53MAPTGAASMN1; SMN2
SCHEMBL19805710 0.75 SDHB (1.00) SDHBTP53MAPTGAASMN1; SMN2
SCHEMBL27899247 0.74 TP53 (0.67) SDHBTP53MAPTGAASMN1; SMN2
SCHEMBL19805808 0.74 SDHB (1.00) SDHBTP53MAPTGAASMN1; SMN2
SCHEMBL19805786 0.71 SDHB (1.00) SDHBTP53MAPTGAASMN1; SMN2
SCHEMBL21019805 0.69 SDHB (1.00) SDHBTP53MAPTGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240268372-A1 Methods and Compositions for Extending Organ and Tissue Preservation MASSACHUSETTS GEN HOSPITAL (US) 2024-08-15 — — US disclosed
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 — — US disclosed
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 — — US disclosed
WO-2022241417-A1 METHODS AND COMPOSITIONS FOR EXTENDING ORGAN AND TISSUE PRESERVATION THE GENERAL HOSPITAL CORPORATION (US) 2022-11-17 — — WO disclosed
US-20210309647-A1 Apoptosis Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-10-07 — — US disclosed
US-11034680-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-06-15 — — US disclosed
US-20190152960-A1 Apoptosis Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2019-05-23 — — US disclosed
WO-2018014802-A1 APOPTOSIS INHIBITORS NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2018-01-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152960-A1 Apoptosis Inhibitors BAX, SDHA, SDHB SDHB 3/4885TP53 160/4885MAPT 2304/4885
US-11725000-B2 Apoptosis inhibitors BAX, SDHA, SDHB SDHB 3/4885TP53 160/4885MAPT 2304/4885
US-11034680-B2 Apoptosis inhibitors BAX, SDHA, SDHB SDHB 3/4885TP53 160/4885MAPT 2304/4885
US-20210309647-A1 Apoptosis Inhibitors BAX, SDHA, SDHB SDHB 3/4885TP53 160/4885MAPT 2304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback